icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
nQeX3yGbEMbVC58d
Listen
